“This is a totally new way of treating back pain,” said Prentiss Lawson Jr., M.D., an associate professor in the UAB Department of Anesthesiology and Perioperative Medicine and program director of the ...
Mainstay Medical Holdings plc has won U.S. FDA approval for its Reactiv8 implantable neurostimulation device. The company is eyeing a commercial launch of the system in early 2021. The FDA approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback